Skip to main content
PMC home page
Thorax logoLink to Thorax
. 2005 Mar;60(3):244–248. doi: 10.1136/thx.2004.034785

Vascular endothelial growth factor gene polymorphism and acute respiratory distress syndrome

A Medford 1, L Keen 1, J Bidwell 1, A Millar 1
PMCID: PMC1747324  PMID: 15741444

Abstract

Background: Non-cardiogenic pulmonary oedema is a characteristic feature of the acute respiratory distress syndrome (ARDS). The properties of vascular endothelial growth factor (VEGF) as a potent vascular permogen and mitogen have led to investigation of its potential role in this condition. Lower VEGF plasma levels have been linked to the presence of the T allele in the +936 CT polymorphism. We hypothesised that the presence of the T allele would be associated with the development and severity of ARDS.

Methods: A cohort of 137 normal subjects, 117 ventilated patients with ARDS, and 103 "at risk" of ARDS were genotyped for the VEGF+936 CT polymorphism. The severity of physiological disturbance and mortality was determined in the ventilated cohorts.

Results: The CT and TT genotype frequencies were increased in ARDS patients compared with both normal subjects (OR 2.01, 95% CI 1.13 to 3.58, p = 0.02) and those "at risk" (OR 2.05, 95% CI 1.02 to 2.20, p = 0.03). In patients with ARDS but not those "at risk", CT and TT genotypes were associated with a higher mean APACHE III score (80.9 (4.3) v 69.3 (2.9), p<0.05).

Conclusion: These data support a role for VEGF in the pathogenesis of ARDS and its associated physiological derangement.

Full Text

The Full Text of this article is available as a PDF (73.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Awata Takuya, Inoue Kiyoaki, Kurihara Susumu, Ohkubo Tomoko, Watanabe Masaki, Inukai Kouichi, Inoue Ikuo, Katayama Shigehiro. A common polymorphism in the 5'-untranslated region of the VEGF gene is associated with diabetic retinopathy in type 2 diabetes. Diabetes. 2002 May;51(5):1635–1639. doi: 10.2337/diabetes.51.5.1635. [DOI] [PubMed] [Google Scholar]
  2. Beck Dieter H., Smith Gary B., Pappachan John V., Millar Brian. External validation of the SAPS II, APACHE II and APACHE III prognostic models in South England: a multicentre study. Intensive Care Med. 2003 Jan 18;29(2):249–256. doi: 10.1007/s00134-002-1607-9. [DOI] [PubMed] [Google Scholar]
  3. Berse B., Brown L. F., Van de Water L., Dvorak H. F., Senger D. R. Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors. Mol Biol Cell. 1992 Feb;3(2):211–220. doi: 10.1091/mbc.3.2.211. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Compernolle Veerle, Brusselmans Koen, Acker Till, Hoet Peter, Tjwa Marc, Beck Heike, Plaisance Stéphane, Dor Yuval, Keshet Eli, Lupu Florea. Loss of HIF-2alpha and inhibition of VEGF impair fetal lung maturation, whereas treatment with VEGF prevents fatal respiratory distress in premature mice. Nat Med. 2002 Jun 10;8(7):702–710. doi: 10.1038/nm721. [DOI] [PubMed] [Google Scholar]
  5. Corne J., Chupp G., Lee C. G., Homer R. J., Zhu Z., Chen Q., Ma B., Du Y., Roux F., McArdle J. IL-13 stimulates vascular endothelial cell growth factor and protects against hyperoxic acute lung injury. J Clin Invest. 2000 Sep;106(6):783–791. doi: 10.1172/JCI9674. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Dvorak H. F., Brown L. F., Detmar M., Dvorak A. M. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol. 1995 May;146(5):1029–1039. [PMC free article] [PubMed] [Google Scholar]
  7. Foster Rebecca R., Hole Rachel, Anderson Karen, Satchell Simon C., Coward Richard J., Mathieson Peter W., Gillatt David A., Saleem Moin A., Bates David O., Harper Steven J. Functional evidence that vascular endothelial growth factor may act as an autocrine factor on human podocytes. Am J Physiol Renal Physiol. 2003 Mar 4;284(6):F1263–F1273. doi: 10.1152/ajprenal.00276.2002. [DOI] [PubMed] [Google Scholar]
  8. Gustincich S., Manfioletti G., Del Sal G., Schneider C., Carninci P. A fast method for high-quality genomic DNA extraction from whole human blood. Biotechniques. 1991 Sep;11(3):298-300, 302. [PubMed] [Google Scholar]
  9. Hanaoka Masayuki, Droma Yunden, Naramoto Atsuhiko, Honda Takayuki, Kobayashi Toshio, Kubo Keishi. Vascular endothelial growth factor in patients with high-altitude pulmonary edema. J Appl Physiol (1985) 2003 Jan 10;94(5):1836–1840. doi: 10.1152/japplphysiol.00575.2002. [DOI] [PubMed] [Google Scholar]
  10. Kaner R. J., Crystal R. G. Compartmentalization of vascular endothelial growth factor to the epithelial surface of the human lung. Mol Med. 2001 Apr;7(4):240–246. [PMC free article] [PubMed] [Google Scholar]
  11. Kaner R. J., Ladetto J. V., Singh R., Fukuda N., Matthay M. A., Crystal R. G. Lung overexpression of the vascular endothelial growth factor gene induces pulmonary edema. Am J Respir Cell Mol Biol. 2000 Jun;22(6):657–664. doi: 10.1165/ajrcmb.22.6.3779. [DOI] [PubMed] [Google Scholar]
  12. Kasahara Y., Tuder R. M., Taraseviciene-Stewart L., Le Cras T. D., Abman S., Hirth P. K., Waltenberger J., Voelkel N. F. Inhibition of VEGF receptors causes lung cell apoptosis and emphysema. J Clin Invest. 2000 Dec;106(11):1311–1319. doi: 10.1172/JCI10259. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Koyama S., Sato E., Tsukadaira A., Haniuda M., Numanami H., Kurai M., Nagai S., Izumi T. Vascular endothelial growth factor mRNA and protein expression in airway epithelial cell lines in vitro. Eur Respir J. 2002 Dec;20(6):1449–1456. doi: 10.1183/09031936.02.00089802. [DOI] [PubMed] [Google Scholar]
  14. Koyama Sekiya, Sato Etsuro, Haniuda Masayuki, Numanami Hiroki, Nagai Sonoko, Izumi Takateru. Decreased level of vascular endothelial growth factor in bronchoalveolar lavage fluid of normal smokers and patients with pulmonary fibrosis. Am J Respir Crit Care Med. 2002 Aug 1;166(3):382–385. doi: 10.1164/rccm.2103112. [DOI] [PubMed] [Google Scholar]
  15. Maitre B., Boussat S., Jean D., Gouge M., Brochard L., Housset B., Adnot S., Delclaux C. Vascular endothelial growth factor synthesis in the acute phase of experimental and clinical lung injury. Eur Respir J. 2001 Jul;18(1):100–106. doi: 10.1183/09031936.01.00074701. [DOI] [PubMed] [Google Scholar]
  16. Matute-Bello G., Liles W. C., Radella F., 2nd, Steinberg K. P., Ruzinski J. T., Jonas M., Chi E. Y., Hudson L. D., Martin T. R. Neutrophil apoptosis in the acute respiratory distress syndrome. Am J Respir Crit Care Med. 1997 Dec;156(6):1969–1977. doi: 10.1164/ajrccm.156.6.96-12081. [DOI] [PubMed] [Google Scholar]
  17. Montgomery A. B., Stager M. A., Carrico C. J., Hudson L. D. Causes of mortality in patients with the adult respiratory distress syndrome. Am Rev Respir Dis. 1985 Sep;132(3):485–489. doi: 10.1164/arrd.1985.132.3.485. [DOI] [PubMed] [Google Scholar]
  18. Morohashi Kazuaki, Takada Toshinori, Omori Kentaro, Suzuki Eiichi, Gejyo Fumitake. Vascular endothelial growth factor gene polymorphisms in Japanese patients with sarcoidosis. Chest. 2003 May;123(5):1520–1526. doi: 10.1378/chest.123.5.1520. [DOI] [PubMed] [Google Scholar]
  19. Oguma Tsuyoshi, Palmer Lyle J., Birben Esra, Sonna Larry A., Asano Koichiro, Lilly Craig M. Role of prostanoid DP receptor variants in susceptibility to asthma. N Engl J Med. 2004 Oct 21;351(17):1752–1763. doi: 10.1056/NEJMoa031785. [DOI] [PubMed] [Google Scholar]
  20. Ohwada A., Yoshioka Y., Iwabuchi K., Nagaoka I., Dambara T., Fukuchi Y. VEGF regulates the proliferation of acid-exposed alveolar lining epithelial cells. Thorax. 2003 Apr;58(4):328–332. doi: 10.1136/thorax.58.4.328. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Renner W., Kotschan S., Hoffmann C., Obermayer-Pietsch B., Pilger E. A common 936 C/T mutation in the gene for vascular endothelial growth factor is associated with vascular endothelial growth factor plasma levels. J Vasc Res. 2000 Nov-Dec;37(6):443–448. doi: 10.1159/000054076. [DOI] [PubMed] [Google Scholar]
  22. Sakao Seiichiro, Tatsumi Koichiro, Hashimoto Tomohiro, Igari Hidetoshi, Shino Yuji, Shirasawa Hiroshi, Kuriyama Takayuki. Vascular endothelial growth factor and the risk of smoking-related COPD. Chest. 2003 Jul;124(1):323–327. doi: 10.1378/chest.124.1.323. [DOI] [PubMed] [Google Scholar]
  23. Thickett D. R., Armstrong L., Christie S. J., Millar A. B. Vascular endothelial growth factor may contribute to increased vascular permeability in acute respiratory distress syndrome. Am J Respir Crit Care Med. 2001 Nov 1;164(9):1601–1605. doi: 10.1164/ajrccm.164.9.2011071. [DOI] [PubMed] [Google Scholar]
  24. Thickett David R., Armstrong Lynne, Millar Ann B. A role for vascular endothelial growth factor in acute and resolving lung injury. Am J Respir Crit Care Med. 2002 Nov 15;166(10):1332–1337. doi: 10.1164/rccm.2105057. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES